Cargando…
The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer
OBJECTIVE: Breast cancer is one of the most prevalent cancers in females worldwide and is one of the leading causes of cancer death and disability in women. Multiple therapies have been applied to breast cancer treatment; however, the long-term survival rate remains low. Although cisplatin has been...
Autores principales: | Wu, Weilu, Yao, Shucong, Huang, Jiapeng, Qing, Jialin, Shi, Qingmei, Huang, Jianping, Qiu, Xingsheng, Zhuang, Yaqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469720/ https://www.ncbi.nlm.nih.gov/pubmed/37664731 http://dx.doi.org/10.1016/j.heliyon.2023.e18779 |
Ejemplares similares
-
Aberrant expression of ZNF268 alters the growth and migration of ovarian cancer cells
por: HU, LI, et al.
Publicado: (2013) -
Knockdown of ZNF268, which Is Transcriptionally Downregulated by GATA-1, Promotes Proliferation of K562 Cells
por: Zeng, Yan, et al.
Publicado: (2012) -
KRAB-Zinc Finger Protein ZNF268a Deficiency Attenuates the Virus-Induced Pro-Inflammatory Response by Preventing IKK Complex Assembly
por: Liu, Yi, et al.
Publicado: (2019) -
ZNF830 mediates cancer chemoresistance through promoting homologous-recombination repair
por: Chen, Guo, et al.
Publicado: (2018) -
Hsa_circRNA_000543 Predicts Poor Prognosis and Promotes Cervical Cancer Cell Progression Through Regulating miR-567/ZNF268 Axis
por: Yao, Zhilan, et al.
Publicado: (2021)